Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Pullback Is a Buying Opportunity

By HEFFX Australia on June 12, 2020   2020, Headline News, Health, Heffx Insights, Investments, MetaStock, Nasdaq, Opinion, Shayne Heffernan, Shayne Heffernan, Stocks, Todays Trade Ideas, Top Stories, US Stocks  

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Pullback Is a Buying Opportunity One company’s loss is another’s gain. Rigel PharmaceuticalsTicker: NASDAQ:RIGLPrice: $1.79 New York-based Pfizer (NYSE: PFE) is the biggest pharmaceutical company in the world, so when it slashes costs and dumps drug candidates left and right, people take note. However sometimes what gets overlooked is that one […]